Early Bird Pricing Ends Soon for Sughrue’s 2026 IP Insights Seminar! Click here for more information.

Skip NavigationSughrue Mion PLLC's logo

Exploring the ramifications of the Federal Circuit’s first decision interpreting 35 USC 102 as amended by the AIA: Helsinn Healthcare v. Teva Pharms

When:
People:
Location:
Hotel Hilton (Mumbai) and Stellar Gymkhana Greater Noida (Delhi), India
Share this page:

Exploring the ramifications of the Federal Circuit’s first decision interpreting 35 USC 102 as amended by the AIA: Helsinn Healthcare v. Teva Pharms" and " Impact of the Federal Circuit’s decision in Novartis v. Noven upholding the invalidation by the PTAB

This website does not track your personal or demographic information, only anonymous usage statistics. To ensure that you are not tracked, we have blocked all embedded content from third party sources like YouTube and SlideShare. Click "Accept Cookies" to enable third-party content. To learn more about our cookie policy, click here.